Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1

Summary

In order to provide a new option for clinical anti-angiogenesis therapy in hepatoma, a randomized controlled study is planed to confirm the effect of Rg3 in combination with TACE on angiogenesis and tumor treatment in advanced hepatocellular carcinoma patients with high expression of Notch1.

Timeline

Start

2012-12

Primary completion

2013-12

Completion

2015-12

Drugs

Indications